about
Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolismChronic inflammation in obesity and the metabolic syndrome.Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6.Chronic Inflammation: Accelerator of Biological Aging.S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation.Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patientsWhat does irritable bowel syndrome share with non-alcoholic fatty liver disease?An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss.Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseasesElevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinaseCalprotectin and platelet aggregation in patients with stable coronary artery diseaseIncreased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight lossMolecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy.S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability.Deficiency of myeloid-related proteins 8 and 14 (Mrp8/Mrp14) does not block inflammaging but prevents steatosis.S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus.The possible role of antimicrobial proteins in obesity-associated immunologic alterations.HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarminsMonitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health.Faecal calprotectin levels before and after weight loss in obese and overweight subjects.Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?Calprotectin--a marker of mortality in COPD? Results from a prospective cohort study.Is calprotectin a marker of tobacco smoke related inflammation?: a pilot study in children.Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes.S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery.Biomarkers in COPD: is mortality the Holy Grail?Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis.Levels of circulating cortisol and cytokines in members of the Canadian Armed Forces: Associations with age, sex and anthropometry.The effects of canrenone on inflammatory markers in patients with metabolic syndrome.S100 Proteins As an Important Regulator of Macrophage Inflammation.Anti-Diabetic Effects of Dung Beetle Glycosaminoglycan on db Mice and Gene Expression Profiling.S100A8/A9 in Inflammation.Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis.Association of circulating calprotectin with lipid profile in axial spondyloarthritis
P2860
Q28085224-27188B31-8FDE-4B8B-BF71-A772C212DF8CQ34035348-AF5136B8-7FFB-4919-A754-24315BACE5AAQ34326387-3680C027-6A5A-4F2C-8851-F4D0A484FACBQ34680346-CEDB3002-84A2-4841-A104-B02D4D19E67EQ34769986-18DC8E7A-9366-4A0B-B321-389E18936074Q34901012-0A641328-4983-4F0C-A937-B9677AD33029Q34983471-1F0DBBEA-B5D2-4EA0-9202-6B43CF3CCE40Q34994872-72209E43-268C-43E3-8AE9-111FE3889A49Q35099739-9680E86C-1629-4DEF-893B-FDF34B78C727Q35405108-866E75B4-D59D-4EF0-8563-D6B4076E9CE8Q35603084-6B65E480-1038-4C2D-80FE-DEB2CE25839FQ35876768-AE39366E-E3D2-43F2-BD33-051C95082701Q36312445-E56C58FE-7943-4671-AD99-D8FB3F3AC3F1Q36631781-687BC3BA-3224-4F11-886E-8B25A4965D27Q37072738-C2368E7A-AACF-4293-8CCD-3077103BB439Q37392515-977E30EA-2511-4BEC-AE7D-405646E6A932Q37436729-6E14C9B4-E45B-4A51-BF88-525B4F5434A7Q37623635-0CF20442-2690-47C4-8793-8888C0B0A7BAQ38206568-F60DA90D-50CD-4ECB-B62B-07C0C71FEA23Q38939435-20A9B124-425D-46A5-8A6C-0732893D232BQ39370979-87A265BA-E8E1-42A4-82F3-0EA942F08C2DQ39641774-1E2E5CE4-38D6-4923-B92F-687D803733E7Q40878625-2310CA6F-92CA-4E54-A404-24895995D188Q42255529-5153CF7D-8EBD-4047-BBEB-9CF8DA38067DQ44068053-39C0A2D4-0F03-407C-AB39-2919D9DF873DQ45002156-5A958900-F3FD-459C-BFC0-554A4AFFB955Q45396344-4F141B3E-DD64-4FAE-9440-11E58F135A6DQ45620558-2A48EB3F-75BD-4E9D-B4F8-61131B8A511EQ45720028-5A513B3D-951C-4CC2-AFB8-0689E7AA8541Q46685103-77D060FB-E73B-4E74-90BD-67938B74ABDAQ47335964-7C52132A-4309-42E8-9449-A5C843F85785Q48484033-40816E74-67E9-46EC-82FF-C213A6DE4927Q49497885-5588808A-7550-4A8B-9111-28EC48A97446Q52311658-3B4557AF-04E8-4478-94AA-5B333F7CC428Q55274411-FBFE5537-A61C-46F9-AC48-FB04C1D36613Q55376762-B9FE6F42-BD2F-4924-8F35-FC69992D279AQ58743766-B62FEA82-1321-4FBA-886D-1FC82B7BA392
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Calprotectin--a novel marker of obesity.
@ast
Calprotectin--a novel marker of obesity.
@en
type
label
Calprotectin--a novel marker of obesity.
@ast
Calprotectin--a novel marker of obesity.
@en
prefLabel
Calprotectin--a novel marker of obesity.
@ast
Calprotectin--a novel marker of obesity.
@en
P2093
P2860
P50
P1433
P1476
Calprotectin--a novel marker of obesity.
@en
P2093
Anne Marie Petersen
Christian Erikstrup
Rikke Krogh-Madsen
P2860
P356
10.1371/JOURNAL.PONE.0007419
P407
P50
P577
2009-10-12T00:00:00Z